Axiom MRC has updated all it's market research reports with the Economic Impact Analysis of COVID19 Pandemic on the market. Our team of analyst are following Comprehensive Three Dimensional (3D) Research Methodology along with large number primary interviews with key industry participants to bring insightful market reports to meet the current market requirements.
The ratio of mean distal coronary pressure to mean aortic pressure is known as the fractional flow reserve (FFR). FFR is able to completely assess the functional importance of a coronary stenosis by incorporating myocardial territory and viability, stenosis severity, and collateral perfusion. It is basically used to determine whether a cardiac patient truly requires a stent or bypass surgery, or if they can be managed just with medications and avoid surgery.
The European fractional flow reserve market has been seeing ample growth from the past few years. The primary driving factor behind the market growth is rapid growth in the European healthcare and medical instrument or device market. Besides, factors such as the massive availability of funding for product research and innovation, increasing geriatric population, rising prevalence rate of diabetes in the countries such as Germany is expanding the market growth. For instance, according to International Diabetes Federation (IDF), in 2019, an estimated 9.5 million adults in the country had diabetes and 4.5 million of these 9.5 million, are undiagnosed.
The study analyses Europe fractional flow reserve market based on technology, application, and country.
Based on technology, invasive monitoring segment is dominated the market in 2020 and is likely to maintain its dominance during the forecast period. The invasive monitoring segment is further bifurcated into FFR measurement systems and pressure guide-wires. A surge in the adoption of specialized pressure guide-wires to measure blood pressure within a coronary artery is major driving factor behind the growth of the segment. However, to determine the fractional flow reserve, new technologies have been developed that may replace conventional pressure wires and adenosine (FFR), which is further likely to propel growth of the non-invasive monitoring segment during the forecast period.
Based on application, single vessel diseases segment is projected to experience fast growth during the estimated time frame. Single vessel disease is sometimes called small vessel heart disease or coronary micro vascular disease. It is the most common disease in women and in people who have high blood pressure or diabetes. Hence increasing cases of diabetes across the Europe region and rising need to prevent this disease is accredited to the growth of the market.
Country wise, the study is comprised of the key countries such as the Germany, France, the UK, Italy, Spain and rest of the Europe. The Germany held the largest market share of Europe fractional flow reserve market and is likely to dominate the market over the estimated time frame. The supportive factors such as continuously increasing cases and deaths due to major heart diseases, adoption of supported prevention measures addressing risk factors such as physical inactivity, smoking, hypertension, alcohol use, and obesity and adoption of new technologies for treatment and prevention of heart disease are attributed to the growth of the market in the country.
The major key players of market includes Abbott Laboratories, Koninklijke Philips N.V, Boston Scientific Corporation, Acist Medical Systems (Subsidiary of Bracco Diagnostic Inc), Opsens, Inc, Heartflow, Inc, Siemens Healthineers, Pie Medical Imaging, Cathworks, Medis Medical Imaging Systems Bv, Medtronic PLC, and Terumo Corporation among others.
The study analyses Europe fractional flow reserve market based on technology, application and geography. Fractional flow reserve market by technology is segmented into invasive monitoring and non-invasive monitoring. The invasive monitoring segment is likely to dominate the Europen market over the forecast period. Increased adoption of invasive monitoring techniques and devices is attributed to the market growth. The market finds application in single-vessel diseases and multi-vessel diseases. The single-vessel diseases segment is likely to register fastest growth in years. Country wise, the study is comprised of Germany, France, the UK, Italy, Spain and rest of the Europe.
Why to buy this report:
